Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextran 40 and Ringer's Lactate in Acute Pancreatitis
NCT06835023Recruiting
- Sponsor
- Satu Mare County Emergency Hospital
- Start
- Jan 2022
- Primary completion
- May 2025
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of dextran in acute pancreatitis (AP) (2 arms), sponsored by Satu Mare County Emergency Hospital. Primary endpoints: Proportion of Participants with Resolution of Systemic Inflammatory Response Syndrome (SIRS) and Mean Percentage Reduction in Serum C-Reactive Protein (CRP) Levels. Started Jan 2022; status: recruiting.
02
Drugs
dextran
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT06835023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06835023.